IFLR1000

Humus Capital acquisition of Biosidus

None
Private acquisition
Select tab

Announced

None

Overview:

  • ACON Bios Investors in partnership with Humus Capital Partners has acquired a majority stake in Biosidus, a pharmaceuticals manufacturer. 

Rani Mehta - Latin America Editor

Jurisdiction:

Argentina

Deal type:

Private acquisition

Practice areas:

Private equity
M&A

Industry sector:

Pharmaceuticals and life sciences

Firm:
Beccar Varela

Party: ACON Investments LLC (Acquirer)

Lawyer: Tomás Allende

Related deals